Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMUMJ7B)

Drug Name

Poly-ICR Drug Info

Synonyms

Poly-ICR (topical, keratosis/genital warts); Poly-ICR (topical, keratosis/genital warts), Akela; Poly-ICR (topical, keratosis/genital warts), Nventa; TLR-3 agonist (topical, acitinic keratosis/genital warts), Nventa; Poly IC-poly-arginine (topical, keratosis/genital warts), Nventa

Indication

Disease Entry	ICD 11	Status	REF
Keratosis	ED56	Investigative	[1]

Cross-matching ID

TTD Drug ID: DMUMJ7B

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Discontinued Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Toll-like receptor 3 (TLR3)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
Rintatolimod	DMYX7VI	Human immunodeficiency virus infection	1C62	Phase 3	[2]
Poly-ICLC	DM2570B	Glioblastoma multiforme	2A00.0	Phase 2	[3]
BCG65-E7	DMAMFXC	Anal intraepithelial neoplasia	2E92.5	Discontinued in Phase 3	[4]
IPH-3102	DMY3BMC	Solid tumour/cancer	2A00-2F9Z	Terminated	[5]
polyIC	DMV486E	Discovery agent	N.A.	Investigative	[6]
Poly IC-poly arginine	DMXA4HY	Keratosis	ED56	Investigative	[1]
Anti-TLR3 mabs	DMN76A4	Autoimmune diabetes	5A10	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 7 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Toll-like receptor 3 (TLR3)	TTD24Y0	TLR3_HUMAN	Agonist	[1]

------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1753).
2	A double-blind, placebo-controlled, randomized, clinical trial of the TLR-3 agonist rintatolimod in severe cases of chronic fatigue syndrome. PLoS One. 2012;7(3):e31334.
3	Toll like receptor-3 ligand poly-ICLC promotes the efficacy of peripheral vaccinations with tumor antigen-derived peptide epitopes in murine CNS tumor models. J Transl Med. 2007 Feb 12;5:10.
4	Serological response to an HPV16 E7 based therapeutic vaccine in women with high-grade cervical dysplasia. Gynecol Oncol. 2010 Feb;116(2):208-12.
5	Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. Oncoimmunology. 2012 August 1; 1(5): 699-716.
6	Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001 Oct 18;413(6857):732-8.